companiesandmarkets.com

Return to Report | Print

Noven Pharmaceuticals Inc - Corporate and Strategic Assessment Report - Company Strategy, SWOT Analysis

http://www.companiesandmarkets.com/Summary-Company-Profile/noven-pharmaceuticals-inc-corporate-and-strategic-assessment-report-company-strategy,-swot-analysis-45942.asp

Report Summary

Introduction

Noven Pharmaceuticals (Noven) is a specialty pharmaceutical company engaged in the discovery, development, manufacture and commercialization of prescription pharmaceutical products. The company markets a portfolio of hormone therapy products including Vivelle Dot, CombiPatch and Daytrana developed using its proprietary transdermal drug delivery technology, DOT Matrix.

Scope

  • Contains corporate strategy, value chain presence and SWOT Analysis
  • Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
  • Includes information on suppliers/ partners, shareholding structure and key employees with biographies


    • Highlights

    Noven is focused on the development of transdermal drug delivery technology and prescription transdermal products. Vivelle Dot, CombiPatch and Daytrana are the company's lead transdermal products. The company has a pipeline of drugs which it develops through its collaborators and licensees.

    The company's total revenues increased at a CAGR of 2% during 2002-2006, from $55 million to $61 million mainly due to revenues recognized under product sales, contract fees, royalty and milestone payments from licensees including Novartis, Novogyne, Shire, and Aventis.

    Noven's revenues are forecast to have an absolute growth of +$108 million with revenues of $61 million in 2006 increasing to $169 million in 2010 primarily due to product sales of Daytrana, Vivelle Dot, Pexeva and Stavzor and the license fees and other revenues earned in connection with the it's collaborations with Novartis, Shire and Novogyne.

    Reasons to Purchase

  • Access all the important information and analysis on the company in a single report
  • Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
  • Gain access to company's adjusted five year financial data along with key ratios and market capitalization

    • Table of Contents

    TABLE OF CONTENTS
    Overview 1
    Catalyst 1
    Summary 1
    Company Structure 6
    Company Overview and Key Facts 6
    Business Description 7
    History 9
    Company Financials 12
    Stock Market Performance 12
    P&L 14
    Balance Sheet 18
    Cash Flow 18
    Geographic Segment Performance 19
    Products & Services 20
    Marketed Products 20
    Pipeline products 22
    AC Forecast Product Sales 25
    Competitors and Strategic Business Relationships 27
    Key Competitors 27
    Key Suppliers 29
    Key Clients 29
    Shareholding Structure 30
    Strategy 31
    Company View 31
    Corporate Strategy 39
    SWOT Analysis 40
    Overview 40
    Strengths 41
    Weaknesses 42
    Opportunities 43
    Threats 44
    Value Chain Analysis 46
    Overview 46
    Discovery and Product Development 47
    Manufacturing 47
    Sales 47
    Scorecard 48
    Overview 48
    Scorecard Analysis 49
    Key Employees 50
    List of Key Employees 50
    Key Employee Biographies 51
    Financial and Operational Overview 56
    Financial and Operational Overview 56
    APPENDIX 58
    Ask the analyst 58
    Datamonitor consulting 58
    Disclaimer 58


    TABLE OF FIGURES
    Figure 1: Noven- Key Strategic Revenues, 2002-2006 ($ Mn) 14
    Figure 2: Noven- Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 15
    Figure 3: Noven- Key Strategic Revenues, 2006-2010 ($ Mn) 25


    TABLE OF TABLES
    Table 1: Noven- Key Facts 6
    Table 2: Noven- Year-End Share Price and Market Capitalization, 2002-2006 ($) 12
    Table 3: Noven- Key Events Impacting Share Price Performance 13
    Table 4: Noven- Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 14
    Table 5: Noven- Operating Cost Ratio Analysis, 2002-2006 (% of total revenues) 17
    Table 6: Noven- Balance Sheet, 2002-2006 ($ Mn) 18
    Table 7: Noven- Cash Flow, 2002-2006 ($ Mn) 18
    Table 9: Noven- Marketed Products 20
    Table 10: Noven- In-house Pipeline Products 22
    Table 11: Noven- Collaboration Pipeline 24
    Table 12: Noven- Key Strategic Revenues, 2006-2010 ($ Mn) 25
    Table 13: Noven- Key Competitors 28
    Table 14: Noven- Key Suppliers 29
    Table 15: Noven- Key Clients 29
    Table 16: Noven- Key Shareholders 30
    Table 17: Noven- SWOT Analysis Summary 40
    Table 18: Noven– Value Chain Analysis 46
    Table 19: Noven- Scorecard 48
    Table 20: Noven- Key Employees 50
    Table 21: Noven- Financial and Operational Overview 56